The benefit of a research paper is more than just having a ticket out of college. The mere process of writing it provides a training ground where one can develop the skills necessary for professional life. Life outside the university is more complex, so while inside, one should already prepare by facing the complexities of […]
Read More
The importance of treating multiple myeloma patients during the COVID-19 pandemic Graham Jackson, MBBS, FRCP, FRCPath, MD, Newcastle upon Tyne Hospitals NHS Trust, Newcastle, UK, discusses how multiple myeloma patients are affected by the COVID-19 infection. A study in the UK, that Prof. Jackson was involved in, indicated that active disease was associated with severe […]
Read More
Multiple Myeloma | Mr. Kanhaiyalal Gupta | Dr. Ganesh Jaishetwar | Yashoda Hospitals I was diagnosed with bone cancer and underwent stem cell transplant under I am so healthy today that it feels like a rebirth. To all those with this condition, undergo the treatment confidently. Find More Patient Testimonial Videos: Patient Speak Like and […]
Read More
Text me about cervical cancer IMAGE: Ford learned that women want to receive text messages about their health care, but presently can’t because of federal medical privacy and telecommunication laws. view more Credit: Photo by National Cancer Institute on Unsplash An estimated 14,480 new cases of invasive cervical cancer will be diagnosed in the United States […]
Read More
GVHD Prophylaxis: Similar Outcomes With PTCy and ATG A newer regimen was no more effective than an older regimen when both were compared for graft versus host disease (GVHD) prophylaxis in patients who underwent reduced-intensity conditioning followed by a hematopoietic stem cell transplant (HSCT) from a 10/10 HLA-matched related or unrelated donor. These results come […]
Read More
Multiple Myeloma Treatment Paradigm Improved Markedly In Recent Years Kenneth C. Anderson, MD, Kraft Family Professor of Medicine at Harvard Medical School and program director of Jerome Lipper Multiple Myeloma Center and LeBow Institute for Myeloma Therapeutics at Dana-Farber Cancer Institute, discusses how he has seen the treatment paradigm transform over the last decade in […]
Read More
Study finds significant variation in biomarker test utilization and treatment for non–small-cell lung … Biomarker testing surveys specific disease-associated molecules to predict treatment response and disease progression; however its use has complicated the diagnosis of non-small-cell lung cancer (NSCLC). In a new study in The Journal of Molecular Diagnosis, published by Elsevier, investigators provide for […]
Read More
Covid: Charities warn cancer death rate could rise Contributors A group of 47 cancer charities says that without urgent action, the UK’s cancer death rate will rise for the first time in decades. NHS figures suggest tens of thousands fewer people started cancer treatment since the first lockdown compared to normal times. One Cancer Voice […]
Read More
Psycho-oncology: A lesser known trump card in cancer care Express News Service KOCHI: Cancer is often an uninvited guest in our lives. It takes insurmountable courage to face such a diagnosis which can be devastating for many people. Yet, we often fail to recognise the other important aspects of the struggle a part from medical intervention. […]
Read More NCCN Updates Clinical Practice Guideline for Multiple Myeloma On March 15, 2021, the National Comprehensive Cancer Network (NCCN) released an update to its clinical practice guideline for multiple myeloma. In the section for therapy for previously treated multiple myeloma, under other regimens, melphalan flufenamide/dexamethasone was added as a category 2A recommendation.—Janelle Bradley Published at Tue, […]
Read More